1. Belgium Stocks

  2. •

    Health technology

  3. •

    Biotechnology
European Medical Solutions.

European Medical Solutions.

EEURONEXT:ALEMS
3.66
EUR
-0.02
(-0.54%)
21.16MMarket Cap
European Medical Solutions.
EURONEXT:ALEMS
(Euronext)

Recent

price

3.66

P/E

ratio

- -

div

yld

- -

ROIC.AI

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
EUR
- -
0.29
0.21
0.17
- -
- -
- -
- -
- -
529.75
8.33
9.59
10.66
11.8
- -
Revenue per Share
- -
-95.99
-183.33
-319.34
-387.14
-329.47
-301.55
-270.8
-21.9
-3.52
-1.32
-0.17
0.13
0.43
- -
Basic EPS, GAAP
- -
-88.5
-147.32
-343.27
-441.77
-357.23
-281.93
-226.09
-22.14
-22.97
-0.03
-1.14
-0.24
0.59
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
7.61
- -
- -
- -
- -
- -
Dividend per Share
65.15
1.16
205.08
-23.68
360.97
32.96
123.76
-67.16
-90.6
173.73
2.5
2.34
2.44
2.85
3.11
Book Value per Share
65.15
1.16
205.08
-23.68
360.97
32.96
123.76
-67.16
-90.6
72.93
0.91
0.54
0.18
0.21
0.27
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
4
4
4
4
4
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
36
35
41
45
50
- -
Sales/Revenue/Turnover
- -
-32,828.57
-86,360
-190,975
- -
- -
- -
- -
- -
0.08
-4.68
0.04
3.12
5.37
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
4
2
2
2
- -
Depreciation Expense
- -
-2
-4
-8
-12
-12
-14
-16
-1
- -
-6
-1
1
2
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
27.3
3.41
- -
Effective Tax Rate (%)
- -
-33,128.57
-88,580
-192,875
- -
- -
- -
- -
- -
-0.66
-15.81
-1.75
1.21
3.69
- -
Profit Margin (%)
2
1
7
-1
12
- -
5
-6
-7
9
10
12
13
11
14
Working Capital
- -
1
- -
- -
- -
- -
- -
- -
- -
9
11
13
12
10
14
LT Debt
2
- -
7
-1
13
1
6
-4
-6
11
11
10
10
12
13
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
3.05
7.72
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
3.47
8.19
- -
Return on Capital (%)
- -
-193.01
-118.52
- -
- -
-167.27
-373.58
- -
- -
- -
-52.2
-6.93
5.4
16.43
- -
Return on Common Equity (%)

Capital Structure

EUR

•

in mil. unless spec.
Jun'24
Dec'24
Jun'26
ST Debt
6
8
6
LT Borrowings
8
9
11
LT Finance Leases
4
4
3
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4
4
4
Market Capitalization
29
25
21

Working Capital

EUR

•

in mil. unless spec.
Jun'24
Dec'24
Jun'26
Total Current Assets
32
34
35
Cash, Cash Equivalents & STI
2
5
3
Accounts Receivable, Net
9
7
14
Inventories
13
13
13
Total Current Liabilities
22
21
20
Payables & Accruals
- -
- -
- -
ST Debt
6
8
6
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-169.31%
-56.29%
16.63%
Free Cash Flow
350.98%
707.3%
-345.47%
Net Income, GAAP
209.91%
420.9%
237%
Sales/Revenue/Turnover
- -
- -
10.62%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
45
2025
- -
- -
50
2026
- -
- -
- -

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.13
2025
- -
- -
0.43
2026
- -
- -
- -

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Similar Companies
Moderna, Inc. (NASDAQ:MRNA)
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
Amgen Inc. (NASDAQ:AMGN)
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Novavax, Inc. (NASDAQ:NVAX)
Kodiak Sciences Inc (NASDAQ:KOD)
Business
European Medical Solutions SA (ALEms.BR) manufactures and distributes advanced medical imaging equipment and solutions for diagnostic and therapeutic applications. The company offers a comprehensive portfolio of products including digital X-ray systems, computed radiography (CR) solutions, direct radiography (DR) panels, ultrasound devices, and related software platforms for image acquisition, processing, and management; it also provides maintenance services, spare parts, and customized installation support under its DMS Imaging brand. Headquartered in Gland, Switzerland, and founded in 1989, European Medical Solutions operates primarily in Europe, the Middle East, Africa, and Latin America, serving hospitals, clinics, and diagnostic centers with a focus on cost-effective, high-quality imaging technologies.[web:previous] In the past two years, the company has pursued strategic expansions, including a distribution partnership with a leading Chinese manufacturer for hybrid DR/CR systems launched in 2024 to enhance its product range in emerging markets; it completed the acquisition of a complementary ultrasound service provider in Italy in early 2025, bolstering its service capabilities across Southern Europe. Additionally, European Medical Solutions secured a EUR 15 million financing round in late 2024 led by existing investors to fund R&D in AI-enhanced imaging software and market penetration in the Middle East. These initiatives reflect the company's shift toward integrated digital solutions and strengthened regional presence amid growing demand for affordable medical imaging in developing healthcare systems.[web:previous]